BioSpace News Archive

Press Releases

ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024

October 30, 2024
·
2 min read
Press Releases

Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024

October 30, 2024
·
1 min read
Press Releases

Enlivex Receives Notice of Allowance for Japanese Patent Application Covering the Use of Allocetra™ in Patients with Osteoarthritis

October 30, 2024
·
4 min read
Press Releases

Pacira to Report Third Quarter 2024 Financial Results on Wednesday November 6, 2024

October 30, 2024
·
1 min read
Press Releases

LENZ Therapeutics to Report Third Quarter Financial Results and Business Update on November 6, 2024

October 30, 2024
·
1 min read
Press Releases

Windtree Therapeutics Initiates SEISMiC C Study of Istaroxime in SCAI Stage C Cardiogenic Shock for Planned Completion of Phase 2b and Transition to Phase 3

October 30, 2024
·
8 min read
Press Releases

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Signing of a Letter of Intent to Acquire its First Florida Interventional Psychiatry Clinics

October 30, 2024
·
4 min read
Press Releases

Triumvira Immunologics to Present New Clinical Data from Ongoing Claudin 18.2 Phase 1 Study in Late-Breaking Oral Presentation at 39th SITC Annual Meeting

October 30, 2024
·
3 min read
Press Releases

BioIVT Launches LEUKOMAX® XL to Provide Researchers with More Cells from a Single Donor Collection per Volume

October 30, 2024
·
2 min read
Press Releases

Ajax Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating AJ1-11095, a First-in-Class Type II JAK2 inhibitor, for the Treatment of Myelofibrosis

October 30, 2024
·
3 min read